AWS Collaborates with Chugai Pharmaceutical Co. on Quantum-Inspired and Constraint Programming Methods for Cyclic Peptide-Protein Docking
Quantum Computing Blog
AWS and Chugai Pharmaceutical Co. collaborated on a quantum computing approach to solve cyclic peptide-protein docking challenges in drug discovery, exploring two computational methods:
- QUBO (Quantum Unconstrained Binary Optimization) approach
- Constraint Programming (CP) approach
- Goal: Determine optimal drug molecule orientation for protein binding
- Used tetrahedral lattice to discretize peptide structure
Key findings:
- QUBO successful for smaller problems (up to 6 peptide residues)
- CP approach more scalable, solving problems with up to 11 peptide residues
- CP method demonstrated better performance when protein was present
- Both methods showed comparable accuracy in matching real protein structures
The research suggests that hybrid classical-quantum approaches may be most promising for complex biomolecular modeling in the future.
The AWS News Feed is currently looking for gold sponsors. If you want to support the AWS community and reach a large audience of AWS professionals, consider sponsoring the AWS News Feed.
Related articles
Nov 19
2025
2025
How Daiichi Sankyo modernized drug discovery using AWS Parallel Computing Service
Nov 26
2025
2025
How Aionics accelerates chemical formulation and discovery with AWS Parallel Computing Service
Jan 30
2024
2024
Accelerating molecule discovery with computational chemistry and Promethium on AWS
Oct 7
2024
2024
Accelerating Drug Discovery with AWS HealthOmics and NVIDIA Blueprints
The AWS News Feed is currently looking for silver sponsors. If you want to support the AWS community and reach a large audience of AWS professionals, consider sponsoring the AWS News Feed.